Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
The FEBS Journal|September 29, 2015
Discoveries and controversies in BCL-2 protein-mediated apoptosisJanet H Zheng, Ariele Viacava Follis, Richard W Kriwacki, et al.Cell Reports|May 17, 2018
Intrinsic Instability of BOK Enables Membrane Permeabilization in ApoptosisJanet H Zheng, Christy R Grace, Cristina D Guibao, et al.Cell|March 8, 2016
BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated DegradationFabien Llambi, Yue-Ming Wang, Bernadette Victor, et al.Molecular Cancer Therapeutics|October 28, 2024
Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47Matthew R Levengood, Christopher M Carosino, Xinqun Zhang, et al.Pageof 1